Shopping Cart
Remove All
Your shopping cart is currently empty
CDK6/9-IN-2 is a highly potent dual inhibitor of CDK6 (IC50 = 15 nM) and CDK9 (IC50 = 22 nM) with selectivity over CDK2, CDK8, and CDK11. It suppresses proliferation in IFN-γ/TNF-α-induced HaCaT cells and inhibits the STAT3 pathway and expression of inflammatory factors. CDK6/9-IN-2 alleviates psoriasis dermatitis and is applicable in psoriasis research.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | CDK6/9-IN-2 is a highly potent dual inhibitor of CDK6 (IC50 = 15 nM) and CDK9 (IC50 = 22 nM) with selectivity over CDK2, CDK8, and CDK11. It suppresses proliferation in IFN-γ/TNF-α-induced HaCaT cells and inhibits the STAT3 pathway and expression of inflammatory factors. CDK6/9-IN-2 alleviates psoriasis dermatitis and is applicable in psoriasis research. |
| Targets&IC50 | CDK6:15 nM |
| In vitro | CDK6/9-IN-2 (Compound 4) effectively inhibits the proliferation of HaCaT cells induced by IFN-γ/TNF-α at a concentration of 80 nM, within a range of 0.0032-2 μM for 2 + 24 hours. At concentrations of 0.1-1 μM for 24 hours, CDK6/9-IN-2 also suppresses the expression of the STAT3 pathway and inflammatory factors in IFN-γ/TNF-α-induced HaCaT cells, thereby reducing inflammatory damage to skin cells. |
| Molecular Weight | 480.01 |
| Formula | C25H30ClN7O |
| Cas No. | 3068529-24-5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.